International Clinical Trial: Psilocybin-assisted treatment for methamphetamine use disorder: A multi-site randomised controlled trial (PsiMA RCT)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001100381) titled 'Psilocybin-assisted treatment for methamphetamine use disorder: A multi-site randomised controlled trial (PsiMA RCT)' on Sept. 4.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel Type of endpoint: Efficacy

Primary Sponsor: University of New South Wales

Condition: Methamphetamine Use Disorder Methamphetamine Use Disorder Mental Health - Addiction

Intervention: Intervention: Psilocybin-assisted psychotherapy (PAT-25)

International Non-proprietary Name (INN): Psilocybin

Dose: Single 25 mg oral dose of...